--2025/Q1-- / 1.031B--
--2024/Q4-- / 1.096B--
Oct 24, 20242024/Q3994.200M / 991.187M--
Jul 25, 20242024/Q21.004B / 1.037B--
--2024/Q1921.000M / 910.902M--
US Stock MarketDetailed Quotes
DXCM DexCom
- 76.440
- +3.610+4.96%
Trading Nov 25 13:00 ET
29.86BMarket Cap46.33P/E (TTM)
77.408High73.270Low2.35MVolume74.200Open72.830Pre Close178.98MTurnover0.61%Turnover Ratio58.80P/E (Static)390.60MShares142.00052wk High15.09P/B29.62BFloat Cap62.34052wk Low--Dividend TTM387.47MShs Float164.863Historical High--Div YieldTTM5.68%Amplitude0.340Historical Low76.122Avg Price1Lot Size
DexCom Key Stats
DexCom Q3 2024 Earnings Date
Currency：USDOct 24, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 991.19M | 994.20M | +3.01M |
| Beat Est. | +1.66% | +1.97% | +0.30% |
| EPS | 0.41 | 0.34 | -0.07 |
| Miss Est. | +41.79% | +17.24% | -17.32% |
Analyst Rating
Oct 31, 2024
DexCom Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
DexCom Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
